UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028272
Receipt number R000032366
Scientific Title Study to establish the safety of using antipyretics with febrile seizures and assess whether acetaminophen could reduce the recurrent risk of febrile seizure in the same fever episode.
Date of disclosure of the study information 2018/01/01
Last modified on 2018/10/09 13:08:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study to establish the safety of using antipyretics with febrile seizures and assess whether acetaminophen could reduce the recurrent risk of febrile seizure in the same fever episode.

Acronym

AAA study

Scientific Title

Study to establish the safety of using antipyretics with febrile seizures and assess whether acetaminophen could reduce the recurrent risk of febrile seizure in the same fever episode.

Scientific Title:Acronym

AAA study

Region

Japan


Condition

Condition

febrile seizure

Classification by specialty

Medicine in general Pediatrics Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to establish the safety of using antipyretics with febrile seizures and assess whether acetaminophen could reduce the recurrent risk of febrile seizure in the same fever episode.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The outcome is the recurrece of febrile seizure in the same fever episode.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

rectal acetaminophen (10mg/ kg) every 6 hours until 24 hours after the onset of febrile seizure

Interventions/Control_2

without any other antipyretic 24 hours after febrile seizure

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 months-old <=

Age-upper limit

72 months-old >=

Gender

Male and Female

Key inclusion criteria

Children and infants who come to emergency room of Hirakata City Hospital with febrile seizures between May 1, 2015, and April 30, 2018, were considered for inclusion in the study.

Key exclusion criteria

1)Patients with seizure over 15 minutes were excluded from the study as status epilepticus.
2)Patients with diarrhea were excluded because it is difficult to put suppositories and other pathologies may be involved such as convulsion with mild gastroenteritis .
3)Patients with epilepsy, chromosomal abnormality, inherited metabolic diseases, brain tumor, cerebral hemorrhage, hydrocephalus, and those with a history of intracranial surgery were excluded.
4)Patients who were used to prevent febrile seizuress with diazepam suppository were excluded.
5)Patients take antihistamine that may increase seizure susceptibility in patients with febrile seizures were also excluded.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinya Murata

Organization

Hirakata City Hospital

Division name

Department of Pediatrics

Zip code


Address

2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan

TEL

+81-72-847-2821

Email

wildwind1980@live.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shinya Murata

Organization

Hirakata City Hospital

Division name

Department of Pediatrics

Zip code


Address

2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan

TEL

+81-72-847-2821

Homepage URL


Email

wildwind1980@live.jp


Sponsor or person

Institute

Department of Pediatrics, Hirakata City Hospital
2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan
Tel: +81-72-847-2821; Fax: +81-72-847-2825

Institute

Department

Personal name



Funding Source

Organization

Department of Pediatrics, Hirakata City Hospital
2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan
Tel: +81-72-847-2821; Fax: +81-72-847-2825

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 03 Month 01 Day

Last follow-up date

2017 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete

2018 Year 03 Month 30 Day

Date analysis concluded

2018 Year 03 Month 30 Day


Other

Other related information

Pediatrics Oct 2018, e20181009; DOI: 10.1542/peds.2018-1009


Management information

Registered date

2017 Year 07 Month 18 Day

Last modified on

2018 Year 10 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032366


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name